id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-351510-8m4930bc	Aquino, Yves S J	Hydroxychloroquine and COVID-19: critiquing the impact of disease public profile on policy and clinical decision-making	2020-07-09		.txt	text/plain	5065	263	48	In particular, we briefly examine the dangers of a heightened public profile in magnifying the inequality of diseases and undermining three key ethical concepts, namely (1) evidence-based practice, (2) sustainable allocation and (3) meaningful consent. 28 In the next three sections, we elaborate the ways in which one disease's public profile, such as COVID-19's, can become so extraordinary that it undermines evidence-based clinical practice, drives unsustainable resource allocation and authorises structural forms of coercive consent. 32 Although there are several morally justifiable reasons for off-label use in general clinical practice, our analysis focusses on the influence of disease public profile on the unapproved or emergency use of HCQ for COVID-19 without sufficient scientific evidence. In this article, we argued that the case of HCQ being touted as potential COVID-19 treatment demonstrates the dangers of a disease's public profile becoming the overarching influence in healthcare decision-making.	./cache/cord-351510-8m4930bc.txt	./txt/cord-351510-8m4930bc.txt